Antibody titer after administration of mRNA‐based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients

Abstract Introduction The mRNA‐based vaccine was released as a COVID‐19 prophylactic; however, its efficacy in organ transplant recipients is unknown. This study aimed to clarify this in liver transplant recipients. Methods Herein, liver transplant recipients from two hospitals who received vaccines...

Cijeli opis

Bibliografski detalji

Glavni autori:	Atsuyoshi Mita, Yasunari Ohno, Yuichi Masuda, Kazuki Yoshizawa, Koji Kubota, Tsuyoshi Notake, Akira Shimizu, Hidetoshi Matsunami, Yuji Soejima
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-09-01
Serija:	Annals of Gastroenterological Surgery
Teme:	liver transplant mRNA‐based vaccine positive humoral response severe acute respiratory syndrome coronavirus 2 vaccination‐induced portal vein thrombosis
Online pristup:	https://doi.org/10.1002/ags3.12677
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!